Hello Gavin,
Recently ( march 2019) our son ( 48 years ) has been diagnosed with colangiocarcinoma .
In the mean while he has had a operation, the wipple- procedure. During the operation were found metastasis in the lymfenodes around de operation-area.
The surgeon has removed them all succesfully- as far as possible ofcourse .
Unfortunately during the operation were found also atypical cells on the intersection of the pancreas.
Our son has also Primary Sclerosing Cholangitis , that makes it more complex.
Our question is :Is in this case the molecular profiling or immunotherapy a option?
In other words: has our son any chance to survive this cancer?
We hope you can give us a honest advice so that we can help our son. In the Netherlands are these options not yet possible
Kind regards,
Laurens en Trieneke Hengst (Holland )